6 – New Cannabinoid-based Drug Slows Fibrosis, Blocks Inflammation in Early Scleroderma Study
A research team has developed a cannabinoid-based drug which stimulates not only one, but two, receptors believed to be involved in fibrosis development in scleroderma. The drug, VCE-004.8, prevented the formation of fibrosis-promoting myofibroblasts in culture and stopped fibrotic changes in a mouse model of dermal fibrosis. Findings from these pre-clinical studies, while early, are promising and may lead to a new therapy for SSc.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?